MESA, AZ — February 20, 2026 — INNOVATION PARTNERS, LLC works to raise awareness of the importance of proactive market access strategy in ensuring patients can access new therapies as quickly and effectively as possible following FDA approval. 

Susan Weidner, Chief Strategy Officer at Innovation Partners, shares her perspective on why early planning matters: 

“Postponing the investment in the appropriate pre-launch activities can’t be made up. The challenge is that you can’t gain that time back.” 

Preparing for market access requires aligning the key components that influence both payer coverage and physician prescribing at the point of care—including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), compendia, and clinical pathways. It also means engaging the full spectrum of stakeholders, particularly community oncologists, and ensuring coding and reimbursement pathways are clear. 

These efforts are critical to helping ensure that FDA approval translates into meaningful and timely patient access. 

Read Susan’s full perspective: FDA Approval May Only Be the First Hurdle in Bringing Cancer Therapies to Patients – Founders Mag. 

About Innovation Partners  

Innovation Partners, LLC (IP) is a high-touch biomedical consulting firm focused on accelerating patient access to innovative therapies and technologies across oncology, hematology, and rare diseases. IP partners with U.S. and global biopharmaceutical, medical device, and medical diagnostic manufacturers throughout the product development continuum to help bring these innovations to patients. 

IP’s mission is to inquire, illuminate, and inform healthcare access at every stage of development—ultimately aiming to make lives better. 

Beyond its depth and breadth of expertise which allows it to navigate the intricacies of the oncology hematology, and rare disease markets, what differentiates IP is its cross-functional approach, integrating medical affairs, market access, and research expertise to deliver tailored, evidence-driven solutions. This comprehensive model enables IP to act as a true strategic partner, providing uniquely designed solutions that support brand development, launch, and long-term access strategies in complex specialty markets. 

Founded in 2011, Innovation Partners has collaborated with more than 85 clients and supported over 100 brands through development and launch initiatives globally. 

Learn more at https://innovationpartners.org/ 

Contact:
Kimberly Drager
Executive Director, Business Development
info@innovationpartners.org